BILL · 2017–18 SESSION

HB 1776: Digoxin & KCl/med procedures

Addressing the use of potassium chloride or digoxin in medical procedures.

Summary

  • Requires a hospital or health care facility, in which an abortion is performed, to report to the department of health whether an intrafetal injection was used in an attempt to induce fetal demise, such as intrafetal potassium chloride or digoxin.

From the Bill Digest (HB 1776), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 30, 2017
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Luanne Van Werven (R-42)
Introduced
January 30, 2017 in the House
Last action
January 8, 2018

AN ACT Relating to the use of potassium chloride or digoxin in medical procedures;

Sponsors

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. By resolution, reintroduced and retained in present status.
  3. By resolution, reintroduced and retained in present status.
  4. By resolution, reintroduced and retained in present status.
  5. First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).

HB 1776 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page